Isaac Francis

Turners Automotive (ASX:TRA) upgraded its earnings guidance for the financial year ending March 31.

Prime Minister Anthony Albanese has confirmed that European Commission President Ursula von der Leyen will arrive in Australia on March 23,

Aclaris Therapeutics (NASDAQ:ACRS) announced it has successfully completed patient enrollment for its Phase 2 clinical trial of bosakitug (ATI-045), an investigational treatment for patients suffering from moderate-to-severe atopic dermatitis.

Ovid Therapeutics (NASDAQ:IVID) announced a $60 million private placement to fund the expansion of its clinical pipeline into tuberous sclerosis complex seizures and infantile spasms.

Pancontinental Energy (ASX:PCL) has secured a 12-month extension for its PEL 87 offshore license from the Ministry of Mines and Energy.

Reward Minerals (ASX:RWD) has executed a binding letter of intent to acquire the highly prospective Mountain Pond Gold Project.

The Australasian Centre for Corporate Responsibility filed an appeal against the Federal Court's recent dismissal of its landmark greenwashing lawsuit against Santos (ASX:STO).

FedEx (NYSE:FDX) has initiated the final phase of its multi-year operational overhaul, announcing plans to close nine shipping facilities across New York and one in Pennsylvania.

One Stop Systems (NASDAQ:OSS) reported a transformative fourth quarter for the fiscal year ended December 31, 2025, marked by explosive top-line growth and a significant shift in its corporate structure.

Lifeward (NASDAQ:LFWD) reported its fourth-quarter and full-year 2025 financial results on Wednesday, March 18, 2026, highlighting a year of significant structural changes and improved reimbursement access.